ACUTE AND LATE TOXICITY IN HIGH-RISK PROSTATE CANCER PATIENTS TREATED WITH ANDROGEN SUPPRESSION AND HYPOFRACTIONATED RADIOTHERAPY (HYPORT) TO THE PROSTATE AND PELVIC NODES

被引:0
|
作者
Faria, Sergio [1 ]
Petrucelli, Mariana [2 ]
Cury, Fabio [1 ]
Duclos, Marie [1 ]
Souhami, Luis [1 ]
机构
[1] McGill Univ, Hlth Ctr, Montreal, PQ, Canada
[2] Radiat Oncol, Rio De Janeiro, Brazil
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
53
引用
收藏
页码:S21 / S21
页数:1
相关论文
共 50 条
  • [31] Adjuvant hypofractionated radiotherapy for prostate cancer: acute toxicity
    Saldi, S.
    Bellavita, R.
    Palumbo, I.
    Mariucci, C.
    Arena, E.
    Lupattelli, M.
    Mendichi, M.
    Tenti, M.
    Tamburi, F.
    Bini, V.
    Aristei, C.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S723 - S723
  • [32] Hypofractionated IMRT With Simultaneous Integrated Boost for High-risk Prostate Cancer Patients: Acute Toxicity Report
    Lecavalier-Barsoum, M.
    Faria, S.
    Ruo, R.
    Cury, F.
    David, M.
    Duclos, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S364 - S364
  • [33] Hypofractionated radiotherapy and androgen deprivation in intermediate risk prostate cancer
    Bracci, S.
    Osti, M. F.
    Agolli, L.
    Bertaccini, L.
    De Sanctis, V.
    Valeriani, M.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S641 - S641
  • [34] Hypofractionated radiotherapy in high-risk prostate cancer using helical tomotherapy
    Pervez, N.
    Pearcey, R.
    Parliament, M.
    Yee, D.
    Amanie, J.
    Murtha, A.
    Pederson, J.
    Mihai, A.
    Mackenzie, M.
    Wachowicz, K.
    Fallone, G.
    RADIOTHERAPY AND ONCOLOGY, 2007, 84 : S94 - S94
  • [35] Benefit of Whole Pelvic Radiotherapy Combined with Neoadjuvant Androgen Deprivation for the High-Risk Prostate Cancer
    Milecki, Piotr
    Baczyk, Maciej
    Skowronek, Janusz
    Antczak, Andrzej
    Kwias, Zbigniew
    Martenka, Piotr
    JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY, 2009,
  • [36] WHOLE-PELVIC NODAL IRRADIATION WITH HYPOFRACTIONATED SIMULTANEOUS INTEGRATED BOOST FOR HIGH-RISK PROSTATE CANCER: OUTCOME AND LATE TOXICITY
    Magli, Alessandro
    Moretti, Eugenia
    Tullio, Annarita
    Ceschia, Tino
    Chiaulon, Germana
    Parisi, Giuseppe
    Signor, Marco Andrea
    Crespi, Margherita
    Foti, Claudio
    De Giorgi, Gioacchino
    Sacco, Cosimo Stanislao
    ANTICANCER RESEARCH, 2017, 37 (04) : 2070 - 2071
  • [37] Acute and Late Rectal Toxicity Following Hypofractionated Radiotherapy in Patients With Prostate Cancer: Results of a Prospective Study
    Kounadis, Georgios
    Syrigos, Nikolaos
    Kougioumtzopoulou, Andromachi
    Bamias, Georgios
    Kotteas, Ilias
    Papatheodoridis, Georgios
    Grapsa, Dimitra
    IN VIVO, 2022, 36 (04): : 1875 - 1880
  • [38] Hypofractionated Acute Toxicity versus conventionally fractionated radiotherapy in patients with Prostate Cancer
    Lohr, Frank
    Ehmann, Michael
    STRAHLENTHERAPIE UND ONKOLOGIE, 2016, 192 (01) : 67 - 69
  • [39] IMAGE-GUIDED INTENSITY MODULATED HYPOFRACTIONATED RADIOTHERAPY IN HIGH-RISK PROSTATE CANCER PATIENTS: TOXICITY AND PRELIMINARY RESULTS
    Valeriani, Maurizio
    Bonome, Paolo
    Osti, Mattia Falchetto
    De Sanctis, Vitaliana
    Bracci, Stefano
    Agolli, Linda
    Enrici, Riccardo Maurizi
    ANTICANCER RESEARCH, 2015, 35 (06) : 3702 - 3702
  • [40] PELVIC IMRT AND HYPOFRACTIONATED SIMULTANEOUS INTEGRATED BOOST TO HIGH-RISK PROSTATE CANCER
    Alessandro, Magli
    De Giorgi, Gioacchino
    Ceschia, Tino
    Crivellaro, Simone
    Marino, Marco
    Parisi, Giuseppe
    Signor, Marco
    Titone, Francesca
    Frea, Bruno
    Fongione, Sandro
    ANTICANCER RESEARCH, 2011, 31 (05) : 1876 - 1877